|
|
Volumn , Issue , 2008, Pages 419-426
|
|
Milestones and monitoring in patients with CML treated with imatinib.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
IMATINIB;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
CANCER STAGING;
CHRONIC MYELOID LEUKEMIA;
DISEASE FREE SURVIVAL;
DRUG RESISTANCE;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENETICS;
HISTOLOGY;
HUMAN;
ONCOGENE;
PATHOLOGY;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
REVIEW;
SPLEEN;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
DISEASE-FREE SURVIVAL;
DRUG RESISTANCE, NEOPLASM;
FUSION PROTEINS, BCR-ABL;
GENES, ABL;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
NEOPLASM STAGING;
PIPERAZINES;
PYRIMIDINES;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
SPLEEN;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 67651184109
PISSN: 15204391
EISSN: None
Source Type: Journal
DOI: 10.1182/asheducation-2008.1.419 Document Type: Review |
|
Times cited : (58)
|
|
References (43)
|
